Related Experiment Video
Updated: Feb 3, 2026

Classical Short-Delay Eyeblink Conditioning in One-Year-Old Children
Published on: September 1, 2018
Growth Hormone Treatment for Short Children Born Small for Gestational Age
Adriane de Andre Cardoso-Demartini1, Alexsandra C Malaquias2, Margaret Cristina da Silva Boguszewski3
1Pediatric Endocrinology Unit, Department of Pediatrics, Federal University of Paraná, Curitiba, Brazil.
Insights
Children born small for gestational age (SGA) face health risks. Growth hormone (GH) therapy can help short SGA children improve stature and body composition, though responses vary.
Area of Science:
- Pediatrics
- Endocrinology
- Neonatology
Background:
- Children born small for gestational age (SGA) are at increased risk for short stature and later health issues.
- Most SGA children achieve spontaneous catch-up growth, but some remain short.
- Potential long-term risks include neurocognitive issues, altered body composition, and cardiovascular disease.
Purpose of the Study:
- To review the indications for growth hormone (GH) therapy in children born SGA.
- To discuss the effects of recombinant human growth hormone (rhGH) on stature and body composition.
- To explore the benefits of rhGH therapy beyond height increase in short SGA children.
Main Methods:
- Literature review of studies on GH therapy in SGA children.
- Analysis of clinical data regarding treatment outcomes.
- Synthesis of current evidence on rhGH efficacy and safety.
Main Results:
- rhGH therapy is indicated for SGA children with persistent short stature, typically initiated after 2-4 years of age.
- Treatment response varies among individuals.
- Benefits extend to improving body composition, not just linear growth.
Conclusions:
- GH therapy is a viable option for improving outcomes in short SGA children.
- The decision to treat should consider individual response and potential benefits beyond height.
- Further research may refine optimal treatment strategies and long-term impact assessments.
Abstract:
Despite the difficulty to define born small for gestational age (SGA), being SGA has been associated with a higher risk of short stature, early-onset and rapid progression of puberty, neurocognitive dysfunctions, alterations in body composition, bone density, glucose and lipid metabolism and increased risk for cardiovascular diseases later in life. The majority of children born SGA experience spontaneous catch-up growth during the first years of life. For those who remain with short stature, treatment with recombinant human growth hormone (rhGH) may be initiated, preferably after 2-4 years of age. Response to treatment is variable. However, the benefits of rhGH go beyond increase in stature as the therapy may also improve body composition. In this review we will cover the indication and effects of GH therapy in short children born SGA.
More Related Videos
Related Concept Videos
The Born-Haber Cycle
Plant Hormones
Types of Hormones
Types of Hormones
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
Hormonal Regulation
Hormonal Regulation

